ATOSSA THERAPEUTICS, INC. Gain (Loss) on Disposition of Intangible Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Gain (Loss) on Disposition of Intangible Assets of -$163.33 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfIntangibleAssets · last filed 2016-11-14
- ATOSSA THERAPEUTICS, INC. gain (loss) on disposition of intangible assets for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. gain (loss) on disposition of intangible assets for the quarter ending 2015-09-30 was $81.33K.
| Period end | Gain (Loss) on Disposition of Intangible Assets 3 month | Gain (Loss) on Disposition of Intangible Assets 6 month | Gain (Loss) on Disposition of Intangible Assets 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$163.33K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$163.33K 10-Q · filed 2016-08-12 | ||
| 2015-09-30 | $81.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $74.80K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$6.53K 10-Q · filed 2016-08-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |